Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1053-2013Class II

LEEP REDIKIT Product No. 6060 In a Loop Electrosurgical Excision Procedure, a thin, low-voltage electrified...

CooperSurgical, Inc. / initiated 2013-02-26 / Terminated / root cause: labeling and UDI

Cooper Surgical, Inc. began a recall of LEEP REDIKIT Product No. 6060 In a Loop Electrosurgical Excision Procedure, a thin, low-voltage electrified wire loop is used to cut out abnormal cervical... on . FDA classified it as Class II and gives the reason as "LEEP RediKit Products (for use in Loop Electrosurgical Excision Procedures) have Xylocaine (Lidocaine) HCL (2%) listed on the tray lid label but this is not included in the contents of the kit, which contained Polocaine...". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-1053-2013
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
CooperSurgical, Inc.
Product
LEEP REDIKIT Product No. 6060 In a Loop Electrosurgical Excision Procedure, a thin, low-voltage electrified wire loop is used to cut out abnormal cervical tissue. The cartridges of Polocaine and Xylocaine with Epinephrine contained in the LEEP RediKit are local anaesthetic which the physician may choose from during the procedure.
Product code
MQB Solid State X-Ray Imager (Flat Panel/Digital Imager)
Reason for recall
LEEP RediKit Products (for use in Loop Electrosurgical Excision Procedures) have Xylocaine (Lidocaine) HCL (2%) listed on the tray lid label but this is not included in the contents of the kit, which contained Polocaine (Mepivacaine) HCL (3%) instead (which was not listed on the tray label).
Root cause tag
labeling and UDI
FDA root cause
Labeling mix-ups
Action
CooperSurgical sent a Recall Notification dated February 26, 2013, to all affected customers. The letter identified the product the problem and the action needed to be taken by the customer. CSI intends to track and quarantine returned product in a segregated location at its manufacturing facility to ensure its separation from acceptable product and prevent its misuse. CSI intends to render used product useless by physical destruction and to rework unused product by correcting the labeling for redistribution. If you have any one of these affected lot numbers in your current inventory, please contact our Customer Service Department at 800-243-2974, or simply complete the attached form and fax to 800-262-0105. Arrangements will be made to replace product in your possession at CooperSurgical's expense. Further instruction and disposition of product will be communicated to you at that time. CooperSurgical deeply regrets the inconvenience that this problem has caused.
Quantity in commerce
4395 kits
Distribution
Nationwide Distribution including Puerto Rico
Product codes and lots
Lot 120716, exp 8-31-13; Lot 116657 exp. 6-30-13; Lot 116658 exp. 5-31-13; Lot 116659 exp. 7-31-13

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1053-2013
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1053-2013Class IITerminatedVoluntary: Firm initiated